Medical-cannabis companies blast New York for ‘clear course for failure’ in state pot-business rollout

  • 📰 MarketWatch
  • ⏱ Reading Time:
  • 31 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 16%
  • Publisher: 97%

Brasil Notícia Notícia

Brasil Últimas Notícias,Brasil Manchetes

Curaleaf, Green Thumb Industries, PharmaCann and Acreage argue that a proliferation of illegal shops and dangerous products is harming the state.

New York state’s largest medical-cannabis companies, which have been barred from wading into the adult-use market for more than two years, are saying they’ve waited long enough for licenses from the state.

While cannabis was legalized in the state more than two years ago, existing medical-pot companies have not been issued any permits, because the state is issuing its first licenses to social-equity applicants under its Conditional Adult-Use Retail Dispensary Program . Such a move could add up to 33 retail cannabis locations to those currently operating in the state and, they said, “provide a dependable supply of safe, tested cannabis products.”

In July, the state’s Office of Cannabis Management approved 212 CAURD licenses, bringing the total number of licenses in the state to 463.

 

Obrigado pelo seu comentário. Seu comentário será publicado após ser revisado.
Resumimos esta notícia para que você possa lê-la rapidamente. Se você se interessou pela notícia, pode ler o texto completo aqui. Consulte Mais informação:

 /  🏆 3. in BR

Brasil Últimas Notícias, Brasil Manchetes